ser64

Another Government Approval, Same Setup as Last Time

Long
NASDAQ:MOTS   None
As in January when MOTS had a patent granted by the US and got clearance from the EU, this time they got FDA clearance for their solution for Upper GI Endoscopies. We are seeing the same magnitude of candles on the 2h and 4h charts. I think for a scalp, if you can get in below 1.5, you can hit 1.62 before a pull back in the first few minutes. Otherwise, I think 1.65-1.75 is a solid entry for a run up with key levels at 1.85, 2.05, 2.2, 2.4, 2.6, and 2.7. After 2.05, personally I'll set a ~10% (depending on my entry) trail stop for the entire position.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.